publication . Article . 2013

Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease

Stephen McDonald; Sunil Badve; Hawley;
Open Access
  • Published: 01 Mar 2013 Journal: Kidney International, volume 83, issue 3, pages 503-510 (issn: 0085-2538, Copyright policy)
  • Publisher: Elsevier BV
There are few reports regarding outcomes of anti-glomerular basement membrane (GBM) disease in patients who underwent renal replacement therapy. To help define this we studied all patients with anti-GBM disease who started renal replacement therapy for end-stage renal disease (ESRD) in Australia and New Zealand (ANZDATA Registry) between 1963 and 2010 encompassing 449 individuals (0.8 percent of all ESRD patients). The median survival on dialysis was 5.93 years with death predicted by older age and a history of pulmonary hemorrhage. Thirteen patients recovered renal function, although 10 subsequently experienced renal death after a median period of 1.05 years. O...
Medical Subject Headings: urologic and male genital diseases
free text keywords: Nephrology
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue